Aurobindo Pharma Revenue: Best Proven Growth in Q2 FY27
Aurobindo Pharma revenue surged in Q2 FY27, with profits up 32.5%. Discover the key factors behind this remarkable growth.
1
AI Sell-off: The Worst Impact on Wall Street
AI sell-off triggers market chaos, affecting Wall Street and risky stocks.
Bitcoin price drop: Worst fall below $80,000 with clear trends
Bitcoin price drop has reached alarming levels as US jobless claims hit a 57-year low, impacting market sentiment.
DTE Energy Q3 earnings: Clear Beat on Estimates
DTE Energy Q3 earnings show a clear beat on estimates, despite a decrease year over year, signaling potential growth opportunities.
Auto ancillary stock: Proven ways to benefit from bonuses
Auto ancillary stock insights: Discover proven benefits of dividends and potential stock splits after a 168% rally in three years.
EPFO WhatsApp Service: Is it the Best Way to Access Benefits?
EPFO WhatsApp Service is now available in Lucknow, offering a quick way to access your benefits.
Kyndryl Q2 2027 earnings: Best proven strategies for growth?
Kyndryl Q2 2027 earnings reveal key insights and strategies for growth after a two-quarter slide. Discover the latest updates.
AMETEK Q3 earnings: What Proven Gains Should Investors Know?
AMETEK Q3 earnings reveal strong organic sales and margin gains, beating estimates. Discover the implications for investors.
Sensex Nifty rise: Best Proven Strategies for Investors
Sensex Nifty rise shows strong market performance as media and metal sectors lead gains. Learn more about the trends.
Asahi India Glass revenue growth: Is it the best news ever?
Asahi India Glass revenue growth has soared to 36.9% in Q2 FY27. Discover what this means for investors and the market.